Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.785
-0.295-4.85%
Volume:25.00M
Turnover:142.77M
Market Cap:9.23B
PE:-18.38
High:5.990
Open:5.990
Low:5.555
Close:6.080
52wk High:11.190
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.09
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.11
PE(LYR):-18.38
PS:18.58

Loading ...

CStone Pharmaceuticals - CEO, Directors, and Senior Management Initiate Joint Share Purchase Plan

THOMSON REUTERS
·
Jun 03

CStone Pharmaceuticals - Share Purchases to Total 2 Mln to 5 Mln Shares From June 2026

THOMSON REUTERS
·
Jun 03

Goldman Sachs Issues Post-ASCO Analysis, Reiterates Buy Rating on CStone with HK$9.44 Target

Stock News
·
Jun 02

CStone Pharmaceuticals Sets 23 June 2026 AGM; Seeks Approval for Director Re-election, 20% Issuance Mandate and Equity Awards to CEO

Bulletin Express
·
Jun 01

CStone Pharma to Seek Shareholder Nod for 20% Issue Mandate, 10% Buy-Back Capacity and CEO Equity Awards

Bulletin Express
·
Jun 01

CStone: ASCO 2026 Data Underscore Robust Efficacy and Safety of Trispecific Antibody CS2009; Phase III Global Trial Planned for Year-End

Bulletin Express
·
Jun 01

CStone presents ASCO data for CS2009 PD-1/VEGF/CTLA-4 trispecific antibody in lung, colorectal cancer trials

Reuters
·
Jun 01

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Pralsetinib’s First Domestic Launch In China

Simply Wall St.
·
May 25

CStone Pharmaceuticals Plans Share Buyback

MT Newswires Live
·
May 13

CStone Announces Plan to Repurchase up to 136.45 Million Shares After ASCO Meeting

Bulletin Express
·
May 13

CSTONE PHARMA-B Announces Plan to Repurchase Up to 136 Million Shares

Stock News
·
May 13

CStone Pharmaceuticals - to Repurchase up to 136.5 Mln Shares in Open Market Under General Mandate

THOMSON REUTERS
·
May 13

CStone Pharmaceuticals plans market buyback of up to 136,450,133 shares

Reuters
·
May 13

CStone Pharmaceuticals Begins Commercial Distribution of Locally Manufactured Pralsetinib

MT Newswires Live
·
May 11

CSTONE PHARMA-B Initiates Nationwide Commercial Distribution of Locally Produced Pralsetinib Capsules

Stock News
·
May 11

CStone launches nationwide distribution of China-made pralsetinib; projects 2026 sales above RMB 0.30 billion

Bulletin Express
·
May 11

CStone expects 2026 pralesatinib capsule sales revenue to top CNY 300 million

Reuters
·
May 11

CStone Pharmaceuticals - Begins Nationwide Commercial Supply of Locally Manufactured Pralsetinib Capsules

THOMSON REUTERS
·
May 11

CStone Pharma Issues 124.23 Million New Shares in April, Expanding Share Base to 1.60 Billion

Bulletin Express
·
May 07

Stock Track | CStone Pharmaceuticals-B Plummets 5.17% Intraday on Share Placement Dilution and Widening Annual Losses

Stock Track
·
Apr 28